A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism

Molecular and Cellular Proteomics

Volumn 9, Issue 12, 2010, Pages 2617-2628

  Cai, Zhen ^a   Zhao, Jiang Sha ^a   Li, Jing Jing ^a   Peng, Dan Ni ^a   Wang, Xiao Yan ^b   Chen, Tian Lu ^b   Qiu, Yun Ping ^b   Chen, Ping Ping ^c   Li, Wen Jie ^c   Xu, Li Yan ^d   Li, En Ming ^d   Tam, Jason P M ^e   Qi, Robert Z ^e   Jia, Wei ^b   Xie, Dong ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b Shanghai Jiao Tong University   (China)

^c ZHENGZHOU UNIVERSITY   (China)

^d SHANTOU UNIVERSITY   (China)

^e HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE; PYRUVIC ACID; RNA;

ADULT; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER STAGING; CARDIA CARCINOMA; CELL GROWTH; CELL MIGRATION; CITRIC ACID CYCLE; DISORDERS OF CARBOHYDRATE METABOLISM; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GLUCOSE TRANSPORT; GLYCOLYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; PRIORITY JOURNAL; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR DIFFERENTIATION; TUMOR VOLUME; WESTERN BLOTTING;

EID: 78650138387     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M110.000661     Document Type: Article

References (56)

1. Wang, L. D., Zheng, S., Zheng, Z. Y., and Casson, A. G. (2003) Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J. Gastroenterol. 9, 1156-1164
2. He, Q. Y., Cheung, Y. H., Leung, S. Y., Yuen, S. T., Chu, K. M., and Chiu, J. F. (2004) Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 4, 3276-3287
3. Botterweck, A. A., Schouten, L. J., Volovics, A., Dorant, E., and van Den Brandt, P. A. (2000) Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int. J. Epidemiol. 29, 645-654
4. Bareiss, D., Stabenow, R., Müller, R., Eisinger, B., Stegmaier, C., Däubler, P., Zeitz, M., and Scherübl, H. (2002) Current epidemiology of carcinoma of the esophagus and cardia in Germany. Dtsch. Med. Wochenschr. 127, 1367-1374
5. Wijnhoven, B. P., Louwman, M. W., Tilanus, H. W., and Coebergh, J. W. (2002) Increased incidence of adenocarcinomas at the gastrooesophageal junction in Dutch males since the 1990s. Eur. J. Gastroenterol. Hepatol. 14, 115-122
6. Blaser, M. J., and Saito, D. (2002) Trends in reported adenocarcinomas of the oesophagus and gastric cardia in Japan. Eur. J. Gastroenterol. Hepatol. 14, 107-113
7. Derakhshan, M. H., Yazdanbod, A., Sadjadi, A. R., Shokoohi, B., McColl, K. E., and Malekzadeh, R. (2004) High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran. Gut 53, 1262-1266 (Pubitemid 39120109)
8. He, Y. T., Hou, J., Chen, Z. F., Qiao, C. Y., Song, G. H., Meng, F. S., Jin, H. X., and Chen, C. (2008) Trends in incidence of esophageal and gastric cardia cancer in high-risk areas in China. Eur. J. Cancer Prev. 17, 71-76 (Pubitemid 351301616)
9. Au, J. S., Cho, W. C., Yip, T. T., and Law, S. C. (2008) Proteomic approach to biomarker discovery in cancer tissue from lung adenocarcinoma among nonsmoking Chinese women in Hong Kong. Cancer Invest. 26, 128-135
10. Liu, D. P., Qi, R. Z., Wang, Y., Chen, P. P., Koeffler, H. P., and Xie, D. (2007) Discovery of stage-related proteins in esophageal squamous cell carcinoma using proteomic analysis. Proteomics Clin. Appl. 1, 312-320
11. Liu, R., Li, Z., Bai, S., Zhang, H., Tang, M., Lei, Y., Chen, L., Liang, S., Zhao, Y. L., Wei, Y., and Huang, C. (2009) Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenic signaling pathway. Mol. Cell. Proteomics 8, 70-85
12. Chaerkady, R., Harsha, H. C., Nalli, A., Gucek, M., Vivekanandan, P., Akhtar, J., Cole, R. N., Simmers, J., Schulick, R. D., Singh, S., Torbenson, M., Pandey, A., and Thuluvath, P. J. (2008) A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. J. Proteome Res. 7, 4289-4298
13. Stemke-Hale, K., Gonzalez-Angulo, A. M., Lluch, A., Neve, R. M., Kuo, W. L., Davies, M., Carey, M, Hu, Z., Guan, Y., Sahin, A., Symmans, W. F., Pusztai, L., Nolden, L. K., Horlings, H., Berns, K., Hung, M. C., van de Vijver, M. J., Valero, V., Gray, J. W., Bernards, R., Mills, G. B., and Hennessy, B. T. (2008) An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res. 68, 6084-6091
14. Khwaja, F. W., Nolen, J. D., Mendrinos, S. E., Lewis, M. M., Olson, J. J., Pohl, J., Van Meir, E. G., Ritchie, J. C., and Brat, D. J. (2006) Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers. Proteomics 6, 6277-6287 (Pubitemid 44935514)
15. Tainsky, M. A. (2009) Genomic and proteomic biomarkers for cancer: a multitude of opportunities. Biochim. Biophys. Acta 1796, 176-193
16. Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., Nyati, M. K., Ahsan, A., Kalyana-Sundaram, S., Han, B., Cao, X., Byun, J., Omenn, G. S., Ghosh, D., Pennathur, S., Alexander, D. C., Berger, A., Shuster, J. R., Wei, J. T., Varambally, S., Beecher, C., and Chinnaiyan, A. M. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914
17. Elton, E. (2005) Esophageal cancer. Dis. Mon. 51, 664-684
18. Qiu, Y., Cai, G., Su, M., Chen, T., Zheng, X., Xu, Y., Ni, Y., Zhao, A., Xu, L. X., Cai, S., and Jia, W. (2009) Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J. Proteome Res. 8, 4844-4850
19. Chen, P. P., Li, W. J., Wang, Y., Zhao, S., Li, D. Y., Feng, L. Y., Shi, X. L., Koeffler, H. P., Tong, X. J., and Xie, D. (2007) Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer. PLoS One 2, e534
20. Qin, X. F., An, D. S., Chen, I. S., and Baltimore, D. (2003) Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. U.S.A. 100, 183-188
21. Xie, D., Miller, C. W., O'Kelly, J., Nakachi, K., Sakashita, A., Said, J. W., Gornbein, J., and Koeffler, H. P. (2001) Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J. Biol. Chem. 276, 14187-14194 (Pubitemid 37391805)
22. Chen, Y., Zhang, H., Xu, A., Li, N., Liu, J., Liu, C., Lv, D., Wu, S., Huang, L., Yang, S., He, D., and Xiao, X. (2006) Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer. Lung Cancer 54, 95-102
23. Wilkinson, N. W., Howe, J., Gay, G., Patel-Parekh, L., Scott-Conner, C., and Donohue, J. (2008) Differences in the pattern of presentation and treatment of proximal and distal gastric cancer: results of the 2001 gastric patient care evaluation. Ann. Surg. Oncol. 15, 1644-1650
24. Falk, J., Carstens, H., Lundell, L., and Albertsson, M. (2007) Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences. Acta Oncol. 46, 1070-1074 (Pubitemid 350058893)
25. Blot, W. J., Devesa, S. S., Kneller, R. W., and Fraumeni, J. F., Jr. (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265, 1287-1289
26. Fan, Y. J., Song, X., Li, J. L., Li, X. M., Liu, B., Wang, R., Fan, Z. M., and Wang, L. D. (2008) Esophageal and gastric cardia cancers on 4238 Chinese patients residing in municipal and rural regions: a histopathological comparison during 24-year period. World J. Surg. 32, 1980-1988
27. Stein, H. J., Feith, M., and Siewert, J. R. (2000) Cancer of the esophagogastric junction. Surg. Oncol. 9, 35-41
28. Ortega, A. D., Sánchez-Aragó, M., Giner-Sánchez, D., Sánchez-Cenizo, L., Willers, I., and Cuezva, J. M. (2009) Glucose avidity of carcinomas. Cancer Lett. 276, 125-135
29. Semenza, G. L. (2007) HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J. Bioenerg. Biomembr. 39, 231-234 (Pubitemid 47619375)
30. Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshita, T., Saito, N., Ochiai, A., Tomita, M., Esumi, H., and Soga, T. (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 69, 4918-4925
31. Robey, I. F., Stephen, R. M., Brown, K. S., Baggett, B. K., Gatenby, R. A., and Gillies, R. J. (2008) Regulation of the Warburg effect in early-passage breast cancer cells. Neoplasia 10, 745-756
32. Altenberg, B., and Greulich, K. O. (2004) Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84, 1014-1020
33. King, A., Selak, M. A., and Gottlieb, E. (2006) Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25, 4675-4682 (Pubitemid 44187617)
34. Yan, H., Bigner, D. D., Velculescu, V., and Parsons, D. W. (2009) Mutant metabolic enzymes are at the origin of gliomas. Cancer Res. 69, 9157-9159
35. Singh, K. K., Desouki, M. M., Franklin, R. B., and Costello, L. C. (2006) Mitochondrial aconitase and citrate metabolism in malignant and non-malignant human prostate tissues. Mol. Cancer 5, 14
36. Laiho, P., Hienonen, T., Mecklin, J. P., Järvinen, H., Karhu, A., Launonen, V., and Aaltonen, L. A. (2003) Mutation and LOH analysis of ACO2 in colorectal cancer: no evidence of biallelic genetic inactivation. J. Med. Genet 40, e73
37. Gatenby, R. A., and Gillies, R. J. (2004) Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891-899
38. Deberardinis, R. J., Sayed, N., Ditsworth, D., and Thompson, C. B. (2008) Brick by brick: metabolism and tumor cell growth. Curr. Opin. Genet. Dev. 18, 54-61
39. Tong, X., Zhao, F., and Thompson, C. B. (2009) The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr. Opin. Genet. Dev. 19, 32-37
40. Hervouet, E., Simonnet, H., and Godinot, C. (2007) Mitochondria and reactive oxygen species in renal cancer. Biochimie 89, 1080-1088 (Pubitemid 47248004)
41. Pelicano, H., Carney, D., and Huang, P. (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist. Updat. 7, 97-110 (Pubitemid 38736063)
42. Santamaría, G., Martínez-Diez, M., Fabregat, I., and Cuezva, J. M. (2006) Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase. Carcinogenesis 27, 925-935
43. Read, J. A., Winter, V. J., Eszes, C. M., Sessions, R. B., and Brady, R. L. (2001) Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase. Proteins 43, 175-185
44. Thorn, C. C., Freeman, T. C., Scott, N., Guillou, P. J., and Jayne, D. G. (2009) Laser microdissection expression profiling of marginal edges of colorectal tumours reveals evidence of increased lactate metabolism in the aggressive phenotype. Gut 58, 404-412
45. Giatromanolaki, A., Sivridis, E., Gatter, K. C., Turley, H., Harris, A. L., and Koukourakis, M. I. (2006) Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis. Gynecol. Oncol. 103, 912-918 (Pubitemid 44821314)
46. Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Gatter, K. C., and Harris, A. L. (2006) Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway-a report of the Tumour Angiogenesis Research Group. J. Clin. Oncol. 24, 4301-4308
47. Shim, H., Dolde, C., Lewis, B. C., Wu, C. S., Dang, G., Jungmann, R. A., Dalla-Favera, R., and Dang, C. V. (1997) c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. U.S.A. 94, 6658-6663
48. Fantin, V. R., St-Pierre, J., and Leder, P. (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9, 425-434 (Pubitemid 43832190)
49. Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Gatter, K. C., and Harris, A. L. (2005) Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia 7, 1-6
50. Wigfield, S. M., Winter, S. C., Giatromanolaki, A., Taylor, J., Koukourakis, M. L., and Harris, A. L. (2008) PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer. Br. J. Cancer 98, 1975-1984
51. Kim, J. W., and Dang, C. V. (2006) Cancer's molecular sweet tooth and the Warburg effect. Cancer Res. 66, 8927-8930
52. Kim, H., Kang, H. J., You, K. T., Kim, S. H., Lee, K. Y., Kim, T. I., Kim, C., Song, S. Y., Kim, H. J., Lee, C., and Kim, H. (2006) Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 6, 3466-3476
53. Huang, K. C., Park, D. C., Ng, S. K., Lee, J. Y., Ni, X., Ng, W. C., Bandera, C. A., Welch, W. R., Berkowitz, R. S., Mok, S. C., and Ng, S. W. (2006) Selenium binding protein 1 in ovarian cancer. Int. J. Cancer 118, 2433-2440
54. Chen, G., Wang, H., Miller, C. T., Thomas, D. G., Gharib, T. G., Misek, D. E., Giordano, T. J., Orringer, M. B., Hanash, S. M., and Beer, D. G. (2004) Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J. Pathol. 202, 321-329
55. Rayman, M. P. (2005) Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc. Nutr. Soc. 64, 527-542 (Pubitemid 41705454)
56. Denkert, C., Budczies, J., Weichert, W., Wohlgemuth, G., Scholz, M., Kind, T., Niesporek, S., Noske, A., Buckendahl, A., Dietel, M., and Fiehn, O. (2008) Metabolite profiling of human colon carcinoma - deregulation of TCA cycle and amino acid turnover. Mol. Cancer 7, 72